Atlas Trials

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Clinical trial NCT01243177 · COMPLETED

Trial details

NCT number
NCT01243177
Sponsor
UCB BIOSCIENCES GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
EpilepsyMonotherapy
Start date
2011-04-01
Primary completion
2015-07-01
Enrollment
888

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.